Triphase Accelerator Corporation expands collaboration with Celgene in developing Marizomib to treat gliomas
Company initiating two new clinical trials for recurrent and newly diagnosed malignant gliomas TORONTO and SAN DIEGO, (May 03, 2016) – Triphase Accelerator Corporation, a private drug development company dedicated to advancing…